Devices › Prosthesis, hip, semi-constrained, metal/ceramic/polymer, cemented or non-porous, uncemented
Device brand name · Head femoral ceramic bilox delta 36mm neutral
Biolox Delta Hip: medical device reports filed with FDA
549 reports name it, 2017–2023. Manufacturer given most often on reports: Encore Medical L P. Product code LZO.
- 549
- device reports naming the brand
- 0% of all MAUDE reports · about 60 a year
- 0
- reports, 12 months to August 2026
- 0 in the 12 months before
- 0%
- classified as malfunction
- 9.1% across the product code
- 0%
- classified as death, as reported
- 0 reports · not verified by FDA
FDA's MAUDE database holds 549 reports that name the brand "Biolox Delta Hip" (head femoral ceramic bilox delta 36mm neutral), received between May 2017 and November 2023; the manufacturer given most often on reports is Encore Medical L P. Spellings of one product vary from report to report.
0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all prosthesis, hip, semi-constrained, metal/ceramic/polymer, cemented or non-porous, uncemented reports (product code LZO) death is recorded in 0.2% and malfunction in 9.1%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are device dislodged or dislocated (32.4%), unstable (4.7%) and insufficient device problem information (1.5%). The patient problems coded most often are joint dislocation, failure of implant and fall. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 32,865 reports carrying product code LZO. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Device dislodged or dislocated | 178 | 32.4% | 18.4% |
| Unstable | 26 | 4.7% | 1.5% |
| Insufficient device problem information | 8 | 1.5% | 18.4% |
| Fracturea broken bone | 7 | 1.3% | 6.9% |
| Patient-device incompatibilitythe device did not suit the patient | 5 | 0.9% | 0.5% |
| Inadequacy of device shape and/or size | 4 | 0.7% | 0.6% |
| Loose or intermittent connection | 3 | 0.5% | 1.9% |
| Loosening of implant not related to bone-ingrowth | 3 | 0.5% | 1.3% |
| Microbial contamination of device | 3 | 0.5% | 0.1% |
| Fitting problem | 2 | 0.4% | 0.4% |
| Output problem | 2 | 0.4% | 0% |
| Positioning problem | 2 | 0.4% | 0.4% |
| Device fell | 1 | 0.2% | 0% |
| Failure to align | 1 | 0.2% | 0% |
| Material separation | 1 | 0.2% | 0.1% |
| Naturally worn | 1 | 0.2% | 2.4% |
| Therapeutic or diagnostic output failure | 1 | 0.2% | 0% |
| Wrong label | 1 | 0.2% | 0.1% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Joint dislocationa dislocated joint | 118 | 21.5% |
| Failure of implant | 33 | 6% |
| Falla fall | 25 | 4.6% |
| Painpain, site not specified | 22 | 4% |
| Appropriate clinical signs, symptoms and conditions term/code not available | 20 | 3.6% |
| Medical device site infectioninfection at the device site | 20 | 3.6% |
| Joint laxity | 11 | 2% |
| Bone fracture(s) | 8 | 1.5% |
| Discomfortdiscomfort | 5 | 0.9% |
| Loss of range of motion | 2 | 0.4% |
| Post operative wound infection | 2 | 0.4% |
| Abscessa collection of pus | 1 | 0.2% |
| Erythemaskin redness | 1 | 0.2% |
| Extraskeletal ossification | 1 | 0.2% |
| Hematomaa collection of blood under the skin or in tissue | 1 | 0.2% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Biolox Delta Hip | Product code LZO | All MAUDE reports |
|---|---|---|---|
| Reports | 549 | 32,865 | 26,136,888 |
| Share of that pool | — | 1.7% | 0% |
| Classified as death, per 1,000 reports | 0 | 2 | 9 |
| Classified as injury | 100% | 89.9% | 36.2% |
| Classified as malfunction | 0% | 9.1% | 62.3% |
| Filed by the manufacturer | 100% | 98.3% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code LZO
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Delta Cer Head 12/14 36mm +1 5 | 1,191 | 59 | 0% |
| Delta Cer Head 12/14 36mm +5 | 914 | 47 | 0% |
| Delta Cer Head 12/14 32mm +1 | 789 | 39 | 0% |
| Delta Cer Head 12/14 32mm +5 | 439 | 12 | 0.2% |
| Unknown Head | 2,250 | 103 | 0.7% |
| BIOLOX Delta | 369 | 255 | 0% |
| Delta Cer Head 12/14 36mm +8 5 | 362 | 22 | 0% |
| UNK Hip Femoral Stem Corail | 523 | 56 | 0.8% |
| Trinity | 673 | 60 | 0.1% |
| Dlt Ts Cer Hd 12/14 36mm +1 5 | 310 | 2 | 0% |
| Mectacer Biolox Delta Femoral Ball Head | 224 | 116 | 0% |
| Modular Dual Mobility Insert | 249 | 6 | 0% |
| Delta Cer Head 12/14 28mm +1 5 | 232 | 13 | 0% |
| Dlt Ts Cer Hd 12/14 36mm +5 0 | 296 | 7 | 0.3% |
| Unknown Stem | 1,857 | 84 | 0.5% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Biolox Delta Hip reports
How many FDA reports name Biolox Delta Hip?
549 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 0 in the latest 12 months.
What kinds of events are reported?
injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
device dislodged or dislocated (32.4%), unstable (4.7%), insufficient device problem information (1.5%), fracture (1.3%) and patient-device incompatibility (0.9%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Biolox Delta Hip was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.